August 02, 2014 1:33 AM ET

Healthcare Providers and Services

Company Overview of Taburit

Executive Profile

Arnon Nagler M.D., M.Sc.

Head of the Bone Marrow Transplantation Department - Sheba Medical Center and Member of Scientific Board, Taburit
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 5 different industries.

See Board Relationships
----

Background

Prof. Arnon Nagler, MD, MSc is a Scientific Founder of Collgard Biopharmaceuticals Ltd. Prof. Nagler serves as Head of the bone marrow transplantation department for Sheba medical center of Taburit. He is a pioneer and world renowned leader in the field of human umbilical cord blood. His first publication addressing stem cell separation and purification from human umbilical cord blood was published in 1994. He established the first cord blood bank in Israel in 1994 and ...

Corporate Headquarters

--
Tel Hashomer, -- --

Israel

Phone: 972 700 500 117
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
Hebrew University of Jerusalem
MS 1985
Tel Aviv University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Taburit, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.